IGFBP5 and colitis: The results demonstrated that IGFBP5 had an anti-inflammatory effect via maintaining immune homeostasis and could efficiently attenuated the severity of DSS-induced colitis, providing an immunological support for the control of inflammation and the treatment of other immune-mediated inflammatory diseases.